GAIN THERAPEUTICS INC's ticker is GANX and the CUSIP is 36269B105. A total of 20 filers reported holding GAIN THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $32,800 | -26.8% | 10,000 | 0.0% | 0.00% | – |
| Q2 2023 | $44,800 | -7.1% | 10,000 | 0.0% | 0.00% | – |
| Q1 2023 | $48,200 | +55.5% | 10,000 | 0.0% | 0.00% | – |
| Q4 2022 | $31,000 | -6.1% | 10,000 | 0.0% | 0.00% | – |
| Q3 2022 | $33,000 | -8.3% | 10,000 | -1.0% | 0.00% | – |
| Q2 2022 | $36,000 | -12.2% | 10,100 | +0.5% | 0.00% | – |
| Q1 2022 | $41,000 | -24.1% | 10,050 | 0.0% | 0.00% | – |
| Q4 2021 | $54,000 | – | 10,050 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|